The Heart Course 2018

The Heart Course 2018 is organized by Center for Emergency Medical Education (CEME) and will be held during Nov 05 - 08, 2018 at Caesars Palace, Las Vegas, Nevada, United States of America.

The target audience for this medical event is physicians, nurses, nurse practitioners, physician assistants, and advanced practice professionals that provide care to patients with acute cardiovascular problems. This CME Conference has been approved for a maximum of 28.75 AMA PRA Category 1 Credits.

Course Description : -
Cardiovascular emergencies must be recognized immediately and treated appropriately to prevent life-threatening consequence. Sometimes only seconds matter to save a life. The skills, tools, and resources to respond to these emergencies are rapidly evolving. The Heart Course provides an opportunity for frontline providers of emergency cardiology to learn, discuss, and apply emerging data, new guidelines, and optimal treatment strategies for the management of cardiac and vascular emergencies.

Learning Objectives : -
• Discuss chest pain risk stratification by exploring the ins and outs of the Heart Score
• Identify the evidence-based strategies for the management of patients with acute coronary syndrome (STEMI, and UA/ NSTEMI), atrial fibrillation, heart failure, transient ischemic attack (TIA), stroke, and cerebral haemorrhage
• Describe the mechanisms of action and optimal evidence-based use of new and emerging cardiovascular medications, including new oral anticoagulants (NOAC) therapy and reversal agents
• Demonstrate state-of-the-art resuscitation strategies for patients presenting with cardiovascular emergencies
• Evaluate and initiate appropriate treatment strategies for high-risk, high-threat electrocardiography (ECG) findings and unusual dysrhythmias
• Discuss the emerging data on current and novel biomarkers in the diagnosis, prognosis, and treatment of cardiovascular disease
• Identify optimal antiplatelet and anticoagulant management strategies for patients with acute coronary syndrome (ACS), atrial fibrillation (AF), venous thromboembolism (VTE), and stroke
• Determine evidence-based best practices in the management of device-related emergencies in patients with cardiac disease, including ventricular assist devices (VADs), pacemakers, and implantable cardioverter defibrillators (ICDs)

Additional details will be posted as soon as they are available.